Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan D Camp

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Science (New York, N.Y.)|May 19, 2007
Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signalingMichael B Major, Nathan D Camp, Jason D Berndt, et al.
Nature Communications|October 16, 2022
Ex vivo engineered human plasma cells exhibit robust protein secretion and long-term engraftment in vivoRene Yu-Hong Cheng, King L Hung, Tingting Zhang, et al.
The Journal of Biological Chemistry|July 7, 2016
Endogenous N-terminal Domain Cleavage Modulates α1D-Adrenergic Receptor PharmacodynamicsTimothy S Kountz, Kyung-Soon Lee, Stacey Aggarwal-Howarth, et al.
Nature Chemical Biology|November 22, 2016
A computationally engineered RAS rheostat reveals RAS-ERK signaling dynamicsJohn C Rose, Po-Ssu Huang, Nathan D Camp, et al.
Chemistry & Biology|November 25, 2010
Chemical-genetic screen identifies riluzole as an enhancer of Wnt/β-catenin signaling in melanomaTravis L Biechele, Nathan D Camp, Daniel M Fass, et al.
Leukemia|July 1, 2021
Activated interleukin-7 receptor signaling drives B-cell acute lymphoblastic leukemia in miceKerri R Thomas, Eric J Allenspach, Nathan D Camp, et al.
Biomaterials|April 2, 2021
Tunable electroconductive decellularized extracellular matrix hydrogels for engineering human cardiac microphysiological systemsJonathan H Tsui, Andrea Leonard, Nathan D Camp, et al.
Science Signaling|May 28, 2009
Bruton's tyrosine kinase revealed as a negative regulator of Wnt-beta-catenin signalingRichard G James, Travis L Biechele, William H Conrad, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 3, 2024
Human plasma cells engineered to secrete bispecifics drive effective in vivo leukemia killingTyler F Hill, Parnal Narvekar, Gregory D Asher, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
Humanized mice enable in vivo evaluation of engineered plasma cell biology and therapeutic functionTyler F Hill, Anna E Helmers, Rene Yu-Hong Cheng, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Science (New York, N.Y.)|May 19, 2007
Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signalingMichael B Major, Nathan D Camp, Jason D Berndt, et al.
Nature Communications|October 16, 2022
Ex vivo engineered human plasma cells exhibit robust protein secretion and long-term engraftment in vivoRene Yu-Hong Cheng, King L Hung, Tingting Zhang, et al.
The Journal of Biological Chemistry|July 7, 2016
Endogenous N-terminal Domain Cleavage Modulates α1D-Adrenergic Receptor PharmacodynamicsTimothy S Kountz, Kyung-Soon Lee, Stacey Aggarwal-Howarth, et al.
Nature Chemical Biology|November 22, 2016
A computationally engineered RAS rheostat reveals RAS-ERK signaling dynamicsJohn C Rose, Po-Ssu Huang, Nathan D Camp, et al.
Chemistry & Biology|November 25, 2010
Chemical-genetic screen identifies riluzole as an enhancer of Wnt/β-catenin signaling in melanomaTravis L Biechele, Nathan D Camp, Daniel M Fass, et al.
Leukemia|July 1, 2021
Activated interleukin-7 receptor signaling drives B-cell acute lymphoblastic leukemia in miceKerri R Thomas, Eric J Allenspach, Nathan D Camp, et al.
Biomaterials|April 2, 2021
Tunable electroconductive decellularized extracellular matrix hydrogels for engineering human cardiac microphysiological systemsJonathan H Tsui, Andrea Leonard, Nathan D Camp, et al.
Science Signaling|May 28, 2009
Bruton's tyrosine kinase revealed as a negative regulator of Wnt-beta-catenin signalingRichard G James, Travis L Biechele, William H Conrad, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 3, 2024
Human plasma cells engineered to secrete bispecifics drive effective in vivo leukemia killingTyler F Hill, Parnal Narvekar, Gregory D Asher, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
Humanized mice enable in vivo evaluation of engineered plasma cell biology and therapeutic functionTyler F Hill, Anna E Helmers, Rene Yu-Hong Cheng, et al.
Pageof 3